We serve Chemical Name:6-Bromo-1,2,3,4-tetrahydro-2-oxo-1,8-naphthyridine-3-carboxylic Acid Methyl Ester CAS:335031-10-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:6-Bromo-1,2,3,4-tetrahydro-2-oxo-1,8-naphthyridine-3-carboxylic Acid Methyl Ester
CAS.NO:335031-10-2
Synonyms:methyl 6-bromo-2-oxo-3,4-dihydro-1H-1,8-naphthyridine-3-carboxylate
Molecular Formula:C10H9BrN2O3
Molecular Weight:285.09400
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:438.965ºC at 760 mmHg
Density:1.622g/cm3
Index of Refraction:1.582
PSA:68.29000
Exact Mass:283.98000
LogP:1.26590
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like methyl 6-bromo-2-oxo-3,4-dihydro-1H-1,8-naphthyridine-3-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,methyl 6-bromo-2-oxo-3,4-dihydro-1H-1,8-naphthyridine-3-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,methyl 6-bromo-2-oxo-3,4-dihydro-1H-1,8-naphthyridine-3-carboxylate Use and application,methyl 6-bromo-2-oxo-3,4-dihydro-1H-1,8-naphthyridine-3-carboxylate technical grade,usp/ep/jp grade.
Related News: In the context of increasingly tight global productive capacity cooperation in the pharmaceutical industry, some multinational pharmaceutical companies have chosen to abandon their original full industrial chain model and shift their focus to market operations. R & D, clinical, and production links reduce costs through outsourcing. Patented APIs came into being. 6-Bromo-1,2,3,4-tetrahydro-2-oxo-1,8-naphthyridine-3-carboxylic Acid Methyl Ester manufacturer International Chemical Investors Group (ICIG) recently announced it has entered into a purchase agreement under which an affiliate of ICIG will acquire the pharmaceutical intermediates business from Genzyme Corporation. 6-Bromo-1,2,3,4-tetrahydro-2-oxo-1,8-naphthyridine-3-carboxylic Acid Methyl Ester supplier In the context of increasingly tight global productive capacity cooperation in the pharmaceutical industry, some multinational pharmaceutical companies have chosen to abandon their original full industrial chain model and shift their focus to market operations. R & D, clinical, and production links reduce costs through outsourcing. Patented APIs came into being. 6-Bromo-1,2,3,4-tetrahydro-2-oxo-1,8-naphthyridine-3-carboxylic Acid Methyl Ester vendor International Chemical Investors Group (ICIG) recently announced it has entered into a purchase agreement under which an affiliate of ICIG will acquire the pharmaceutical intermediates business from Genzyme Corporation. 6-Bromo-1,2,3,4-tetrahydro-2-oxo-1,8-naphthyridine-3-carboxylic Acid Methyl Ester factory With the improvement of people’s living standards and the aging degree, the demand for medicines has been increasing for a long time. Therefore, the transfer from finished medicines to bulk medicines has greatly promoted the demand for bulk medicines.
